ADHD
Akili slashes 40% of staff, shifts to OTC sales for digital therapies
Anika Sharma
In response to the challenges faced by prescription digital therapeutics companies, Akili is taking a new approach to navigate the ...
Mallinckrodt Launches New FDA-Approved ADHD Drug Lisdexamfetamine
Anika Sharma
Mallinckrodt, a global specialty pharmaceutical company, has made waves with an announcement that’s set to reshape the Attention-Deficit/Hyperactivity Disorder (ADHD) ...
Takeda’s Vyvanse faces generic competition after 16 years of ADHD dominance
Anika Sharma
Vyvanse, a blockbuster drug for attention-deficit/hyperactivity disorder (ADHD) and binge-eating disorder, has been the top choice for many patients and ...
